There is no constant in healthcare legislation. In the United States, political opponents continue to argue over the future of former President Barack Obama’s Affordable Care Act: Democrats seek to broaden healthcare’s accessibility, while Republicans aim to minimize taxes and shift subsidies away from health-related issues. This is further complicated by conflicting polling surrounding hot-button healthcare issues. These variables and shifts in prioritization leave little room for compromise, inroads, and even public understanding.
Political feuds surrounding healthcare might not be as contentious everywhere, but that doesn’t mean the situation is comfortable. Around the world, medical providers, pharmaceutical companies, and businesses in the biotech and medical device industries must keep a close watch on legislative shifts.
All of this becomes exhausting after a while. In turn, medical companies must plan ahead to navigate a legislative minefield.